Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

DRI Healthcare Trust T.DHT.UN

Alternate Symbol(s):  DHTRF

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence in the United States; European Union; Japan, and Rest of the world.


TSX:DHT.UN - Post by User

Post by Bamsmbaon Feb 10, 2022 3:29pm
251 Views
Post# 34417884

Mackenzie Financial exceeded 12.75% of outstanding shares…

Mackenzie Financial exceeded 12.75% of outstanding shares…In December 2021. I interpreted this as good news. 

I pulled this report from Sedar... when looking for some... ANY type of news.  Somtimes I get nervous about this stock when I don't hear ANTHYING... even a rumour for long periods of time. 

I would have thought we would hear something... perhaps another royalty agreement with "so much in the pipeline."  I suppose they could be waiting to see the approval of the new drug from CTI Biopharma.  Well... at least that stock is well off it's lows from the FDA approval delay... so that is at least not negative.

Anyone hear of something... anything? 

GTLA

BAMSMBA
<< Previous
Bullboard Posts
Next >>